Published: 3 May 2024
Author(s): Lixia Qiu, Shuang Zhang, Yang Zhang, Calvin Q Pan, Jing Zhang
Section: Letter to the Editor

We were inspired by the recent article by van Erpecum and Dalekos [1], which proposed new horizons in the diagnosis and management of patients with metabolic dysfunction-associated steatotic liver disease (MASLD). In response, we evaluated the newly introduced nomenclature for steatotic liver disease (SLD) [2] and its implications in an elderly cohort in Beijing.

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness